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ABROGATION OF CHRONIC REJECTION IN A MURINE MODEL 
OF AORTIC ALLOTRANSPLANTATION BY PRIOR INDUCTION OF 
DONOR-SPECIFIC TOLERANCE l 
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THOMAS E. STARZL,2 AND ABDUL S. RA02.3•4 
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University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261 
Aortic allotransplantation in mice has been well es-
tablished as a model of choice to study the evolvement 
of chronic rejection, the etiopathology of which is be-
lieved to be that of immune origin. This has prompted 
the postulation that prior induction of donor-specific 
tolerance would attenuate or abrogate the underlying 
events that culminate in posttransplant arteriosclero-
sis. To study the effects of donor-specific tolerance on 
chronic rejection, we performed orthotopic liver 
transplantation without immunosuppression in mice 
30 days before aortic allotransplantation across C57B1I 
IOJ (H2b )--C3H (H2k) strain combinations (group 1m. 
Aortic allografting in syngeneic (group I; C3H--C3H) 
and allogeneic (group II, C57BII1OJ ...... C3H) animals 
served as controls. No morphological changes were 
evidenced in the transplanted aortas in group I ani-
mals. Contrarily, aortic allografts in group II animals 
underwent a self-limiting acute cellular rejection, 
which resolved completely and was succeeded by day 
30 after transplantation by histopathological changes 
pathognomonic of chronic rejection. There was evi-
dence for diffuse myointimal thickening, progressive 
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concentric luminal narrowing, and patchy destruction 
of internal elastic membranes resulting in massive 
vascular obliteration by day 120 after transplantation. 
It was of interest that no arteriosclerotic changes 
were observed for the duration of follow-up (up to 120 
days after transplantation) in transplanted aortas (liv-
er donor-type) harvested from animals in group III. 
However, vasculopathy was prominent in third-party 
aortic grafts transplanted into tolerant recipients. 
Taken together, these data suggest that prior induction 
of tolerance abrogates the development of chronic rejec-
tion; this protection seems to be donor specific. 
The most common cause for late organ allograft failure is 
chronic rejection (CR*); its incidence in organs surviving 
more than 5 years is up to 43%, 50%, and 60% for trans-
planted kidneys (1), lungs (2), and hearts (3), respectively. 
Conversely, its prevalence is much lower (3.6-16.8%) in long-
surviving liver allografts (4). Although the factors underlying 
the changes pathognomonic of posttransplant obliterative 
vasculopathy are poorly understood, they nevertheless seem 
to be multifactorial (5-7). In addition to ischemia-reperfu-
sion, allogeneic immune responses have been postulated to 
play a role in the pathophysiology of delayed graft failure 
(8-10). 
* Abbreviations: ACR, acute cellular rejection: AO, aorta; AOTx. aortic 
transplantation; CR, chronic rejection: DST, donor-specific tolerance; Ig, 
immunoglobulin; OB. obliterative bronchiolitis; OLTx, orthotopic liver 
transplantation; Tx, transplantation: a-smA. a-smooth muscle actin. 
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Of greater significance is the observation that once estab-
lished, histopathological changes characteristic of CR are 
irreversible and somewhat refractory to exogenous interven-
tion. This has necessitated the development of therapeutic 
strategies for its attenuation or abrogation. Given its im-
mune etiopathology, it has been argued that prior induction 
of donor-specific tolerance (DST) in organ transplant recipi-
ents may mitigate the evolvement of CR. This postulation 
has been verified experimentally in rats (11-15) and in a 
mouse model of cardiac allotransplantation (16). Similar ob-
servations have also been made in long-surviving human 
lung (17, 18) and renal (19) allograft recipients. 
Given the availability of cellular and molecular probes in 
mice, we have elected to develop further a murine model of 
posttransplant arteriosclerosis. In this study, we report the 
progressive evolvement of CR in a mouse model of aortic 
allotransplantation (20, 21). Immune modulation and its ef-
fect on the development of vasculopathy was examined by 
prior orthotopic liver transplantation (OLTx), a procedure 
invariably as~oeiated with spontaneous allograft acceptance, 
establishment of microchimerism, and the induction of DST 
(22). 
MATERw..s AND METHODS 
Animals 
Inbred male mice ofthe C57BVIOJ (BI0; H2b ), BALBlcByJ <H2d ), 
and C3H <H2l<) strains were purchased from Jackson Laboratory 
(Bar Harbor, ME) and housed in a pathogen-free facility, provided 
with Purina rodent chow and tap water ad libitum, and used at 
10-12 weeks of age. 
Surgical Procedures 
Operative procedures were executed under inhalation anesthesia 
(Metofane; Methoxyflurane, Pitman-Moore, Inc., Mundelein, IL) us-
ing a dissection microscope (M-32, Leica, Switzerland). 
Aortic transplantation (AOTx) was performed by a method de-
scribed previously (20). A segment <0.6 em) of donor thoracic aorta 
(Am was anastomosed (end-to-sidel to the infrarenal portion of the 
recipient abdominal AO. The section of the recipient AO between the 
anastomotic sites was ligated and severed, converting the anastomo-
sis into a quasi end-to-end. 
Using a combination suture and cuff technique, the liver was 
orthotopically transplanted using a method described elsewhere (22, 
23). The hepatic artery was not reconstructed, and cholecystectomy 
was performed with bile duct patency assured using a polyethylene 
tube stent. 
Experimental Groups 
The recipients of AOTx were divided into three groups (n=5/ 
group; Fig. 1): group I (syngeneic), C3H-C3H without prior OLTx; 
group II (allogeneic), B10--C3H without prior OLTx; and group III, 
OLTx across BlO--C3H strain combination, followed 30 days later 
by AOTx from either BIO (liver donor-strain) or BALBIcByJ (third 
party I. The experiments in each group were repeated 2-3 times to 
corroborate these findings. The recipients were not immunosup-
pressed. 
Tissue Procurement and Processing 
At a predetermined interval after AOTx (day O. 6. 10. 20, 30. or 
>50 after Tx) and under inhalation anesthesia. the abdominal cavity 
was exposed. The entire segment of the grafted AO was harvested. 
fixed for 2-3 davs in 104 neutral buffered formalin (VWR. Cleve-
land. OHIo and 'processed for embedment into paraffin (Sherwood 
Medical. St. Louis. MOL For histopathological analysis. sections 14 
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FIGURE 1. Schematic representation of various experimental groups 
used in this study. BID: C57BV10J. 
JLm thick) were obtained, mounted onto precleaned slides. and 
stained with hematoxylin and eosin (Surgipath, Richmond, IL). For 
detection of elastic fibers and collagen, Verhoetf-van-Gieson's and 
Mason's trichrome staining, respectively, were performed (25). 
Immunohistochemical Staining 
For detection of a-smooth muscle actin (a-smA) mouse anti-human 
monoclonal antibody (immunoglobulin [lg)G2a; DAKO Corp., Carpin-
teria, CAl was used (26, 27). Given the highly conserved sequence of 
its target antigen, this antibody has been shown to cross-react with 
a-smA from various species. The primary antibody was identified by 
biotinylated horse anti-mouse IgG (Vector Laboratories Inc., Burlin-
game, CAl. For visualization of secondary antibody, the ABC (VEC-
TASTIN; Vector Laboratories) immunoperoxidase system was used 
with coloration being developed using chromogen 3-amino-9-ethyl-
carbazol (ScyTek Laboratories Inc., Logan, UTI. Sections were coun-
terstained with hematoxylin for light microscopy. 
RESULTS 
Graft Outcome 
For the establishment of this technique and subsequently 
for the completion of this study, we have performed over 300 
aortic transplants (allogeneic. n=275; syngeneic. n=25) us-
ing the quasi end-to-end procedure (20). With the exception 
of initial failures. which were largely a result of technical 
problems. the survival has been >98'7r (reproducible). throm-
bosis being the most frequent cause of graft loss. 
-
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FIGURE 2. Cross-sections of aortic grafts harvested at various times after Tx across syngeneic (C57BlIIO-+C57BVIO) and allogeneic 
(C57BIJI0-+C3Hl mouse strain combinations. Hematoxylin and eosin-stained sections of transplanted allogeneic aortas (without prior 
OLTx) at days 0 (Al, 6 (B), 10 (Cl, 30 (D), and 50 (El after Tx. The onset (B) and resolution (C) of ACR, followed by the development of 
progressively worsening CR (D and El, is distinct. Contrarily, hematoxylin and eosin-stained sections of syngeneic grafts at day 50 after Tx 
IF) display normal vascular morphology. Verhoeff-van Gieson stained (for elastic membranes) sections of allogeneic aortas (without prior 
OLTx) at days 0 (Gl, 30 (R), and 60 m after Tx. Note the intact internal elastic limiting membrane on day 0 (G) with its progressive 
L 
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Histopathological and Immunohistochemical Analysis 
Syngeneic ECPe~CPeF AOTx. Grafts were harvested at 
various times after Tx for ascertainment of histopathological 
abnormalities. Although most of the samples obtained at 
days 4, 6, and 10 exhibited minimal edema of the media, this 
resolved by day 20 after Tx. However, despite these changes 
in the media, the integrity of the intima and the overlying 
endothelium (Fig. 2F) were preserved in grafts harvested at 
various times after Tx. More important, cellular infiltration 
was not discerned in any of the sections examined, and 
a-smA + cells were not visualized in the intima of the synge-
neic grafts, a finding comparable with that observed in native 
aortas. 
Allogeneic (C57BlI fl~CPeF AOTx without prior OLTx. 
To rule out abnormalities uniquely associated with postsur-
gical ischemia, aortic allografts were harvested immediately 
after revascularization (day 0), and their morphology was 
compared with that of native aortas. No microscopic aberra-
tion was evidenced in the endothelium (Fig. 2A, inset, ar-
rows), which rested on an unaltered layer of the internal 
elastic limiting membranes. Staining for elastic fibers (by 
Verhoeff van Gieson's stain) demonstrated the presence of an 
intact internal elastic limiting membrane (Fig. 2G). More 
important, unlike that in the media, no a-smA + cells were 
observed in the intima (Fig. 2.1), a finding consistent with 
that in the native aorta. 
However, by day 6 after Tx, there was incontrovertible 
evidence for cellular rejection underscored by massive inti-
mal infiltration of mononuclear cells (Fig. 2B, inset) with 
minimal invasion of the media and adventitia. Without ex-
ogenous immunosuppression, cellular infiltration underwent 
self-resolution such that by day 10 after Tx, the presence of 
mononuclear cells was barely discernible in the intima of the 
vessel (Fig. 2C). There was, nevertheless, evidence for minor 
residual damage as a result of acute cellular rejection (ACR) 
indicated by patchy endothelial cell denudation and necrosis 
(Fig. 2C, inset). 
Over the next few days, histopathological abnormalities 
pathognomonic of ACR abated only to be supplanted by day 
30 with changes characteristic of posttransplant arterioscle-
rosis (Fig. 2, D, H, and K). There was evidence for diffuse and 
concentric intimal thickening (Fig. 2D, inset), primarily a 
result of marked proliferation of Q-smA + cells (Fig. 2K). 
Additionally, patchy destruction of the internal elastic limit-
ing membrane (Fig. 2H) and initiation of intimal deposition 
of fibrous tissue and collagen was evident. It is noteworthy 
that this progressively worsening lesion resulted in gradual 
occlusion of the vascular lumen (Fig. 2, I and L), which was 
primarily a result of incessant proliferation of a-smA + cells 
and collagen deposition in the intima (Fig. 2, I and L). 
Allogeneic (C57BlI fl~CPeF AOTx with prior OLTx. To 
ascertain whether prior induction of DST would attenuate 
the development of posttransplant vasculopathy, we per-
formed an orthotopic transplant of an allogeneic (BlO) liver 
30 days before AOTx. This decision was based on our previ-
ous demonstration that across virtually all MHC-disparate 
mouse strain combinations, orthotopically transplanted liv-
ers were spontaneously accepted without the need for exog-
enous immunosuppression (22). More important, this phe-
nomenon was associated universally with stable long-term 
establishment of multilineage donor cell chimerism and in-
duction of DST. Similar to that observed in syngeneic but 
unlike that in allogeneic grafts, the morphology of the trans-
planted aorta obtained from the liver donor (EI0) strain 
animals when harvested at days 4, 6, and 10 after Tx exhib-
ited no evidence of mononuclear cell infiltration and endo-
thelial cell denudation and necrosis. Furthermore, there was 
no evidence of histopathological changes distinctive of CR in 
aortic allografts procured at up to 60 days after Tx (or 90 days 
after OLTx; Figure 2, M, N, and 0). To ascertain whether this 
liver-induced protection is indeed donor specific, we trans-
planted third party (BALBclByJ) aortic allografts, all of 
which underwent self-limiting acute cellular crisis, which 
preceded the development of changes characteristically wit-
nessed in posttransplant arteriopathy (data not shown). 
DISCUSSION 
Despite the advent of potent immunosuppressive agents, 
the development of posttransplant arteriosclerosis still re-
mains a significant cause for delayed organ allograft dysfunc-
tion (1-3, 6,7). Although the etiopathology ofCR has not yet 
been fully elucidated, it is believed to be multifactorial (5-7); 
ischemia-reperfusion injury (28), donor age, histoincompat-
ibility (29), and cytomegalovirus infection (30) have been 
implicated. Additionally, the intensity and frequency of ACR 
have also been shown to be directly correlated to the severity 
of posttransplant vaculopathy, suggesting an immune etiol-
ogy (8, 9, 31,32). The latter argument has been substantiated 
further by observations in rodents, in whom prior induction 
of DST has been shown to mitigate the subsequent develop-
ment of CR (11-16). 
Studies in humans have also yielded similar observations. 
Keenan et a1. (17) have reported that the presence of micro-
chimerism and the establishment of donor-specific hypore-
sponsiveness was associated with lower incidence of obliter-
ative bronchiolitis (OB) in lung allotransplant recipients. 
These findings have been corroborated by Reinsmoen et a1. 
(18), who showed that in lung allograft recipients exhibiting 
donor-specific hyporesponsiveness who were 2-8.5 years af-
ter Tx, no OB was in evidence. On the contrary, 9 of 17 (53%) 
patients who were responsive to donor antigens in in vitro 
proliferative assays developed OB (18). Similar observations 
have also been made in long-term renal allograft recipients 
(19). In our prospective clinical trial of concomitant donor 
thickening (arrows I and destruction by day 60 after Tx (Ii. The progressive intimal thickening evidenced in previous images was largely a 
result of proliferation of a-smA + cells as can be distinguished by immunohistochemical staining of cross-sections of allogeneic aorta (without 
pnor OL Tx) at days 30 (KI and 50 (L) after implantation. No a-smA' structures were evident in aortas obtained immediately after Tx (J I. 
When aortic allo~afts from C57BVIO mice were transplanted into C3H recipients that had previously (30 days earlier I received OLTx of a 
donor-strain tvpe. no evidence of CR was wItnessed as is depicted in hematoxylin and eosin 1M I· and VerhoetT-"an Gieson IN and Ol-stained 
sectIOns obtained at days 20 (M). 30 IN). and 60 \01 after AOTx. Magnification. x 100 (A. D. E. F. G. H.I. K. L. M. and NJ; ) 200 IB and C,: 
x 400 (0 I; )( 1000 (J I. Inset. x 1000 except In D and L ( '400 l. Please note that these arlo' original magnification; any "anations introduced by 
photo processing have been disregarded. 
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bone marrow infusion and organ allotransplantation, we 
have also documented increased incidence of CR in contem-
poraneously accrued non-marrow-augmented lung trans-
plant recipients as compared with that of the study (marrow-
augmented) patients (33). 
Although these foregoing observations have underscored 
the pivotal role for allogeneic immune responses (among 
others) in the development of CR, the cellular and molecular 
events responsible for this ominous outcome have not, how-
ever, been precisely elucidated. This latter fact, combined 
with the unavailability of an effective therapeutic regimen, 
has compounded clinical management of organ allograft re-
cipients, in whom the diagnosis of CR is associated fre-
quently with an undesirable outcome. 
The relative paucity of cellular and molecular probes in 
rats limits the utility of this species for more explicit studies. 
It is for this reason that murine models of posttransplant 
arteriosclerosis, in whom this limitation does not exist, be 
considered for such analyses. Heterotopic cardiac allotrans-
plantation in mice is perhaps an appropriate model to study 
the evolvement ofCR (16). However, the perioperative use in 
this model of immunosuppressive therapy to promote graft 
acceptance greatly restricts the ability to study acute phase 
events, which are generally considered to predispose to the 
eventual development of post transplant arteriosclerosis (31). 
In a similar manner, morphological changes in the mouse 
model of heterotopic respiratory airways allotransplantation 
are quite divergent from those observed in human lung 
transplant recipients, thus greatly limiting its usefulness 
(34). 
We report here the evolution of CR in a mouse model of 
aortic allotransplantation, which similar to that in rats (35), 
undergoes spontaneously resolving ACR. Lymphocytic infil-
tration in the subendothelial space of the intima and the 
media was observed during the first week after Tx. However, 
by days 8-10 after Tx, infiltration markedly decreased such 
that by day 20, there was little or no evidence for residual 
post inflammatory tissue damage. In addition, at this stage, 
no endothelial denudation but minimal myointimal prolifer-
ation was discernible. It was of interest that no immunosup-
pressive therapy was required for resolution of ACR and 
subsequent allograft acceptance. 
However, by day 30 after Tx, morphological features of CR 
indistinguishable from those in humans were evident. These 
included diffuse and concentric luminal narrowing, patchy 
destruction of internal elastic limiting membrane, and exten-
sive intimal thickening as a result of marked proliferation of 
a-smA + smooth muscle cells. It was of interest that, at this 
stage, no fibrous tissue and/or collagen deposition was no-
ticeable in the thickened intima. This progressively worsen-
ing lesion resulted in massive occlusion of the vessel by day 
120 after Tx. No morphological aberrations developed in syn-
geneic grafts during the course offollow-up, further substan-
tiating the hypothesis that allogeneic immune responses play 
a seminal role in the development of CR. 
Having verified that the histopathological changes in allo-
transplanted mouse aortas are in consonance with those 
witnessed in clinical posttransplant vasculopathy. we pro-
ceeded to ascertain the effect of prior induction of DST on the 
subsequent development of CR. For this purpose, we elected 
to perform OLTx, which in addition to being spontaneously 
accepted has also been shown to impart to the recipient a 
state of DST (22l. Thirty days after OLTx, when DST has 
been established. the recipients were challenged with either 
donor <B1O) or third-party (BALBdByJ) aortic allografts. Al-
though third-party grafts developed (by day 30 after implan-
tation) changes reminiscent of CR, aortic allografts from 
donor-strain animals were morphologically indistinguishable 
from syngeneic grafts or normal aortas when examined dur-
ing the course of follow-up (up to 120 days after Tx). In 
conclusion, given its morphological and developmental simi-
larities to posttransplant vasculopathy in clinical organ al-
lograft recipients, we strongly advocate the use of aortic 
allotransplantation in mice as a model of choice for detailed 
study of the pathogenesis of CR. 
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